Edition:
United States

China Biologic Products Holdings Inc (CBPO.OQ)

CBPO.OQ on NASDAQ Stock Exchange Global Select Market

76.54USD
15 Dec 2017
Change (% chg)

$2.13 (+2.86%)
Prev Close
$74.41
Open
$74.96
Day's High
$76.54
Day's Low
$74.89
Volume
118,041
Avg. Vol
110,699
52-wk High
$120.01
52-wk Low
$74.01

Chart for

About

China Biologic Products Holdings, Inc. is a biopharmaceutical company. The Company is principally engaged in the research, development, manufacturing and sales of human plasma-based biopharmaceutical products in China. It operates through the manufacture and sales of human plasma products segment. China Biologic has a product... (more)

Overall

Beta: 1.82
Market Cap(Mil.): $2,113.22
Shares Outstanding(Mil.): 27.61
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 198.20 16.04
EPS (TTM): -- -- --
ROI: -- -11.76 34.69
ROE: -- -36.72 15.46

BRIEF-China Biologic Receives Operating Permit For New Collection Facility In Ju County In Shandong Province

* CHINA BIOLOGIC RECEIVES OPERATING PERMIT FOR NEW COLLECTION FACILITY IN JU COUNTY IN SHANDONG PROVINCE Source text for Eikon: Further company coverage:

Dec 15 2017

BRIEF-China Biologic posts Q3 adj. earnings per share $1.38

* China Biologic reports unaudited financial results for the third quarter of 2017

Nov 01 2017

BRIEF-China Biologic agrees to acquire Tianxinfu from PWM

* China Biologic Products Holdings Inc - ‍It has agreed to acquire 80% equity interest in Tianxinfu (Beijing) Medical Appliance Co., Ltd​

Oct 12 2017

BRIEF-China Biologic receives approval for commercial manufacturing of human fibrinogen

* China Biologic receives approval for commercial manufacturing of human fibrinogen

Oct 09 2017

BRIEF-China Biologic Q2 earnings per share $1.09

* China Biologic reports financial results for the second quarter of 2017

Aug 02 2017

Earnings vs. Estimates